Cell-based immunotherapy for cancer has produced promising results. The overall mission of CSTI lead by Dr. Khalid Shah is to develop and test novel targeted cell-based immunotherapies for cancer. CSTI capitalizes on the unique expertise in interdisciplinary research spanning the biology of different cell types, gene editing/engineering and cell signaling, as well as our proven abilities to synthesize new insights from disparate fields, to lead interdisciplinary teams into new territory.
